Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Mcpherson’S Limited ( (AU:MCP) ) has provided an announcement.
McPherson’s Limited has announced a strategic shift in its operating model by transitioning from direct-to-store orders to utilizing a third-party logistics provider and pharmacy wholesalers. This change is marked by a new three-year agreement with Symbion Pty Ltd, starting June 2025, which will handle an estimated $10-$15 million in annual revenue previously managed under the direct-to-store model. This move is expected to streamline operations and potentially enhance McPherson’s market positioning by leveraging Symbion’s distribution capabilities.
More about Mcpherson’S Limited
McPherson’s Limited is a supplier of essential health, beauty, and wellness products in Australia, with core household brands such as ‘Manicare’, ‘Lady Jayne’, ‘Dr LeWinns’, ‘Swisspers’, and ‘Fusion Health’. The company focuses on growing these brands through pharmacy, grocery, and e-commerce channels. It also offers a portfolio of popular brands in segments like haircare, vitamins, supplements, fragrance, and nutrition. Headquartered in Sydney, McPherson’s operates offices in Melbourne, Auckland, Hong Kong, and Shanghai, and is listed on the Australian Securities Exchange.
YTD Price Performance: -25.56%
Average Trading Volume: 3,066
Technical Sentiment Signal: Buy
Current Market Cap: €20.62M
Find detailed analytics on MCP stock on TipRanks’ Stock Analysis page.